CELLTRION

Live / Registered — Registered — international registration renewed (as of 17 Aug 2022)

What this means for you

Registered since 10 Jul 2012. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 Jul 2032: the §71 ten-year affidavit of use).

Record

Serial number
79101488
Registration number
4169803
Mark type
Design + words
Filed
01 Apr 2011
Published for opposition
24 Apr 2012
Registered
10 Jul 2012
Next maintenance filing
§71 ten-year affidavit of use, due by 10 Jul 2032 (grace period to 10 Jan 2033)
Attorney of record
Kisuk Lee

Goods and services

  • Class 005 — Pharmaceuticals: [ Vaccines; medicines for sensory organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of sensory organ; agents affecting peripheral nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the peripheral nervous system; agents for immunity adjustment, namely, pharmaceutical preparations for the prevention and treatment of disorders of the immune system; biological preparations for medical purposes; amino acids for medical purposes; antibiotic preparations; agents for respiratory organs, namely, pharmaceutical preparations for the prevention and treatment of disorders of respiratory organs; chemotherapeutics; reagents for measuring Hepatitis B Surface antibody, namely, medical diagnostic reagents for detecting Hepatitis B surface antibody; diagnostic preparations for medical use; AIDS, acquired immune deficiency syndrome diagnostic agents, namely, diagnostic preparation for medical use; AIDS, acquired immune deficiency syndrome vaccines; agents affecting central nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the nervous system; veterinary vaccines; agents for tumor treatment, namely, pharmaceutical preparations for the treatment of tumor; agents for urogenital organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of urogenital organs; kits for protein test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a protein related to a disease; kits for gene test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a gene related to a disease; biopharmaceuticals for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; biopharmaceutical preparations, namely, polypeptides, proteins, monoclonal antibodies, hormones for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone deficiency diseases; biotherapeutic preparations and substances for medical purposes; biotechnological preparations for medical purposes; pharmaceuticals; chemical preparations for pharmaceutical purposes, namely, chemical reagents for medical purposes; chemico-pharmaceutical preparations ]
  • Class 035 — Advertising and business services: Wholesale distributorships featuring pharmaceutical products; retail store services featuring pharmaceutical products; business intermediary services in the field of pharmaceutical products; wholesale distributorships featuring biopharmaceutical products; retail store services featuring biopharmaceutical products; business intermediary services in the field of biopharmaceutical products
  • Class 040 — Treatment of materials: Treatment of biopharmaceutical materials, namely, processing finished products from raw biopharmaceutical materials; treatment service of biopharmaceutical materials for others, namely, processing finished products from raw biopharmaceutical materials for others; contract manufacturing service for others in the field of biopharmaceuticals; contract manufacturing service in the field of pharmaceuticals
  • Class 042 — Scientific and technological services: Pharmaceutical research and development; [ bacteriological research; biological research; research and development for new products for others; material testing; chemistry services, namely, chemistry consultation; chemical research and analysis; technology outsourcing services on biopharmaceuticals manufacturing, namely, conducting biopharmaceutical research services for others; consulting services in the field of biotechnology; pharmaceutical drug development services with animal cell; scientific research related to genetically modified plant; biotechnology research; ] biopharmaceutical research and development [; medical product testing; technology outsourcing services on selecting medicines, namely, conducting pharmaceutical research services for others ]
  • Class 044 — Medical, beauty and agricultural services: [ Rental of medical and health care equipment; medical product information, namely, providing an interactive holistic web site featuring health information and patient initiated, patient authorized, fee-for-service, holistic approach distance healing sessions based on the patient's specific set of symptoms, medical profile and medical record analysis and patient benefit information concerning organic and holistic products and services; medical clinics, namely, conducting clinical trials of new products for medical purposes; hospitals; medical assistance services; biopharmaceutical consulting service ]

Owner

Prior registrations

Board proceedings on this mark

The owner also pleads this mark in 3 other Board proceedings.

Prosecution history

  • 21 Oct 2023 — CHANGE OF NAME/ADDRESS REC'D FROM IB
  • 02 Dec 2022 — CHANGE OF NAME/ADDRESS REC'D FROM IB
  • 17 Aug 2022 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
  • 17 Aug 2022 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
  • 16 Aug 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 18 Mar 2022 — TEAS SECTION 71 & 15 RECEIVED
  • 05 Oct 2021 — CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
  • 18 Sept 2021 — CHANGE OF NAME/ADDRESS REC'D FROM IB
  • 10 Sept 2021 — CORRECTION TRANSACTION RECEIVED FROM IB
  • 06 Aug 2021 — CHANGE OF OWNER RECEIVED FROM IB
  • 10 Jul 2021 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
  • 02 Jul 2021 — INTERNATIONAL REGISTRATION RENEWED
  • 30 Apr 2021 — NEW REPRESENTATIVE AT IB RECEIVED
  • 19 Apr 2019 — PARTIAL INVALIDATION PROCESSED BY THE IB
  • 23 Mar 2019 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

View this trademark record on Rightsy